In Yulin, Guangxi, Wu Shichun, the founding partner of Meihua Venture Capital and chairman of Zhongzhu Medical Holdings Co., Ltd., recently stated during a research visit to Yulin Guinan Hospital that AI is not a replacement for doctors. Instead, it frees physicians from repetitive tasks, enabling high-quality services to reach more families.

He plans to integrate capital and technological resources deeply with hospital clinical services and traditional Chinese medicine innovation. Using a model of "capital, technology, and healthcare," he aims to bring tech project resources to the local area. Wu also mentioned that, based on Yulin's industrial needs, he will facilitate the flow of high-quality capital and innovative resources into real-world medical settings.

Public information shows that Yulin City holds a significant position in the pharmaceutical industry, earning the title of "China's Southern Medicine Capital." It is home to the third-largest specialized Chinese herbal medicine market in China, with annual trade volume exceeding 10 billion yuan, forming a comprehensive and massive transaction and industrial ecosystem for traditional Chinese medicine. Guinan Hospital, located here, is naturally situated in a resource-rich area of the health industry.